Structural Basis for Gluten Intolerance in Celiac Sprue

Abstract

Celiac Sprue, a widely prevalent autoimmune disease of the small intestine, is induced in genetically susceptible individuals by exposure to dietary gluten. A 33-mer peptide was identified that has several characteristics suggesting it is the primary initiator of the inflammatory response to gluten in Celiac Sprue patients. In vitro and in vivo studies in rats and humans demonstrated that it is stable toward breakdown by all gastric, pancreatic, and intestinal brush-border membrane proteases. The peptide reacted with tissue transglutaminase, the major autoantigen in Celiac Sprue, with substantially greater selectivity than known natural substrates of this extracellular enzyme. It was a potent inducer of gut-derived human T cell lines from 14 of 14 Celiac Sprue patients. Homologs of this peptide were found in all food grains that are toxic to Celiac Sprue patients but are absent from all nontoxic food grains. The peptide could be detoxified in in vitro and in vivo assays by exposure to a bacterial prolyl endopeptidase, suggesting a strategy for oral peptidase supplement therapy for Celiac Sprue.

Celiac disease in the Red Sea state of Sudan

“…As the pathophysiology of celiac disease gets clearer, new methods of treatment are being developed including orally active drugs. 30 …”

Celiac Disease: Pathophysiology, Clinical Manifestations, and Associated Autoimmune Conditions

“…4) Finally, since gliadin is unusually rich in proline residues, there is an intrinsic resistance to digestion in the intestines along with a preference for binding to DQ2 molecules. An example is a 33-amino acid residue of gliadin identified to be stable despite digestion with gastric, pancreatic, and intestinal brushborder membrane proteases, with preserved immunogenicity (21). It is believed that the absorption of such larger intact peptides of gliadin allows the immunogenic response to occur.…”

Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters

“…Mono-or polyaminylation of glutamine residues of proteins by a transglutaminase occurs in the presence of different amines instead of lysine residues of proteins providing important physiological regulation including the activation of insulin secretion by serotonylation of the Rab small GTPase (Paulmann et al 2009), and histamine incorporation into fibrinogen (Lai and Greenberg 2013) or gliadin peptides (Qiao et al 2005) which potentially modulate inflammatory processes. In the absence of any amine donor substrate deamidation of the glutamine residue takes place leading to, for example, a more potent antigen in celiac disease (Shan et al 2002). The incorporation of a peptide or biogenic amine and deamidation or polyamine linkage modify charges in the target proteins switching on or off the biological process in which they participate.…”